Diabetes Therapy
High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in diabetes mellitus
Published in Obesity and Diabetes Week, February 13th, 2006
"Diabetic cardiomyopathy is characterized by cardiac dysfunction. This study was designed to examine the effect of benfotiamine, a lipophilic derivative of thiamine, on streptozotocin (STZ)-induced cardiac contractile dysfunction in mouse cardiomyocytes," scientists in the United States report.
A.F. Ceylanisik and colleagues at the University of Wyoming explained, "Adult male FVB mice were made diabetic with a single injection of STZ (200 mg/kg ip). Fourteen days later, control and diabetic (fasting plasma glucose >13.9 mM) mice were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Improved insulin resistance after weight loss is not linked to adiponectin changes - Diet & Nutrition
Long-chain polyunsaturated fatty acid diet may protect obese against metabolic syndrome - Drug Safety
Orlistat and micronized fenofibrate are safe and effective for overweight and obese - Obesity Therapy
(+)-Z-BDDA may have applications in treating obesity and metabolic syndrome complications - Type 2 Diabetes
Vaspin expression in adipose tissue may be linked to obesity and type 2 diabetes - Anesthesia
Anesthesia can cause sustained hyperglycemia in C57/BL6J mice - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
